Create Free Account

By creating account you will get access to hot stocks & personalised emails

Monash IVF Group Ltd

Healthcare AU MVF

1.15AUD
-0.015(1.29%)

Last update at 2024-11-13T05:10:00Z

Day Range

1.151.17
LowHigh

52 Week Range

1.121.50
LowHigh

Fundamentals

  • Previous Close 1.17
  • Market Cap459.77M
  • Volume1158025
  • P/E Ratio-
  • Dividend Yield4.24%
  • EBITDA2.09M
  • Revenue TTM255.22M
  • Revenue Per Share TTM0.66
  • Gross Profit TTM 72.83M
  • Diluted EPS TTM-0.02

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax 29.84M 26.22M 35.94M 16.13M 27.48M
Minority interest -0.12700M -0.09600M 2.26M 2.31M 0.22M
Net income 21.84M 18.41M 25.15M 11.73M 19.85M
Selling general administrative 74.13M 66.88M 55.77M 49.00M 48.09M
Selling and marketing expenses 6.92M 6.43M 6.39M 5.72M 4.99M
Gross profit 191.19M 172.51M 163.71M 129.01M 136.43M
Reconciled depreciation 15.34M 14.79M 12.89M 11.00M 5.07M
Ebit 31.07M 26.65M 37.01M 20.80M 31.29M
Ebitda 46.41M 41.44M 49.90M 31.80M 36.37M
Depreciation and amortization 15.34M 14.79M 12.89M 11.00M 5.07M
Non operating income net other - - - - -
Operating income 35.00M 28.37M 33.59M 22.37M 31.29M
Other operating expenses 101.04M 87.70M 89.46M 65.40M 119.34M
Interest expense 1.23M 0.43M 1.07M 4.67M 3.81M
Tax provision 7.87M 7.72M 10.44M 4.37M 7.68M
Interest income 0.03M 0.00400M 0.00100M 5.71M 3.65M
Net interest income -3.27900M -2.14700M -1.06500M -4.67200M -3.80200M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 7.87M 7.72M 10.44M 4.37M 7.68M
Total revenue 213.59M 192.29M 183.60M 145.42M 151.98M
Total operating expenses 158.07M 144.14M 125.32M 107.18M 103.79M
Cost of revenue 22.40M 19.79M 19.89M 16.41M 15.55M
Total other income expense net -5.15757M -2.14700M 2.61M -6.24600M -3.80900M
Discontinued operations - - - - -
Net income from continuing ops 21.97M 18.50M 25.50M 11.76M 19.81M
Net income applicable to common shares 21.84M 18.41M 25.15M 11.73M 19.85M
Preferred stock and other adjustments - - - - -
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Total assets 508.47M 421.89M 380.82M 351.17M 349.03M
Intangible assets - 25.32M 25.72M 26.81M 29.00M
Earning assets - - - - -
Other current assets 5.68M 4.98M 4.06M 2.94M 3.96M
Total liab 261.81M 146.82M 110.92M 82.23M 96.91M
Total stockholder equity 241.91M 273.20M 267.92M 266.68M 249.81M
Deferred long term liab - - - - -
Other current liab 30.44M 5.71M 0.48M 1.21M 0.60M
Common stock 506.79M 506.79M 506.79M 506.79M 506.79M
Capital stock - 506.79M 506.79M 506.79M 506.79M
Retained earnings -162.73500M -162.73500M -162.73500M -162.73500M -162.73500M
Other liab - 6.61M 2.65M 2.64M 3.79M
Good will 273.35M 255.13M 233.17M 233.17M 233.17M
Other assets - 0.68M 0.17M 0.46M 0.18M
Cash 11.33M 8.01M 7.87M 8.76M 15.07M
Cash and equivalents - 1.44M 0.97M 1.75M 2.00M
Total current liabilities 118.82M 46.50M 38.17M 41.08M 37.86M
Current deferred revenue 77.32M 32.61M 27.22M 30.16M 31.92M
Net debt 124.04M 92.03M 69.36M 37.23M 42.50M
Short term debt 7.99M 6.33M 7.13M 7.47M 2.32M
Short long term debt - - - 1.63M -
Short long term debt total 135.37M 100.04M 77.23M 45.99M 57.57M
Other stockholder equity -0.00000M -409.40800M -404.71300M -403.06000M -386.58600M
Property plant equipment - 109.39M 95.06M 67.29M 55.62M
Total current assets 55.78M 29.94M 25.64M 22.50M 30.66M
Long term investments - 1.28M 1.05M 0.94M 0.39M
Net tangible assets - -7.25100M 9.02M 6.70M -12.35700M
Short term investments - 0.30M - - -
Net receivables 30.59M 10.53M 8.45M 6.58M 7.68M
Long term debt - 38.87M 9.76M 0.00000M 18.94M
Inventory 8.18M 6.43M 5.25M 4.22M 3.95M
Accounts payable 3.08M 1.85M 3.34M 2.25M 3.02M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -102.14600M -70.85000M -76.13400M -77.37300M -94.24300M
Additional paid in capital - - - - -
Common stock total equity - - - - 506.79M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 23.97M 0.47M -355.00500M -327.50500M -318.18300M
Deferred long term asset charges - - - - -
Non current assets total 452.69M 391.96M 355.17M 328.67M 318.36M
Capital lease obligations - 61.17M 67.47M 44.36M 38.63M
Long term debt total - 93.71M 70.10M 38.52M 55.26M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -40.50800M -15.16200M -11.28700M -10.56300M -6.53600M
Change to liabilities 1.96M 0.68M -1.95800M 5.09M 1.63M
Total cashflows from investing activities -40.50800M -15.16200M -11.28700M -10.56300M -6.53600M
Net borrowings 19.82M -0.26300M -25.21900M -76.92300M -9.00000M
Total cash from financing activities 1.51M -17.62900M -39.07800M -9.70200M -26.11400M
Change to operating activities 1.15M 0.35M 1.47M 0.99M 0.77M
Net income 21.84M 18.41M 25.33M 11.73M 19.85M
Change in cash 0.13M -0.88700M -6.31100M 10.79M 0.43M
Begin period cash flow 7.87M 8.76M 15.07M 4.28M 3.85M
End period cash flow 8.01M 7.87M 8.76M 15.07M 4.28M
Total cash from operating activities 39.12M 31.89M 43.98M 31.08M 33.09M
Issuance of capital stock - - - 77.53M -
Depreciation 12.88M 12.35M 10.70M 9.11M 3.71M
Other cashflows from investing activities -12.71900M -3.39900M -1.25400M -3.05600M -
Dividends paid 17.14M 16.75M 13.13M 7.07M 13.19M
Change to inventory -1.17600M -1.03700M -0.26800M 0.03M -0.12900M
Change to account receivables -2.98400M -2.70200M 0.64M -3.81100M 0.32M
Sale purchase of stock - - - -3.45000M -77.53200M
Other cashflows from financing activities 31.65M 17.25M -8.29400M -6.98900M -3.92200M
Change to netincome 3.13M 4.07M 2.23M 7.25M 4.87M
Capital expenditures 27.79M 11.76M 10.03M 7.51M 6.54M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -4.16000M -3.73900M 0.37M -3.77700M 0.19M
Stock based compensation 0.32M 0.25M 0.11M 0.00597M 0.00357M
Other non cash items 4.40M 1.13M 7.95M 10.25M 9.53M
Free cash flow 11.33M 20.13M 33.95M 23.57M 26.56M

Peer Comparison

Sector: Healthcare Industry: Diagnostics & Research

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
MVF
Monash IVF Group Ltd		 -0.015 1.29% 1.15 - 14.99 1.80 1.91 2.30 54.34
SHL
Sonic Healthcare Ltd		 -0.23 0.86% 26.46 25.36 22.32 1.45 1.65 1.90 10.21
HLS
Healius Ltd		 -0.015 0.95% 1.56 - 163.93 0.65 1.09 1.53 10.14
ACL
Australian Clinical Labs Ltd		 -0.01 0.28% 3.58 30.50 12.24 1.06 4.17 1.48 6.03
IDX
Integral Diagnostics Ltd		 -0.1 3.19% 3.03 - 20.96 1.52 2.33 2.17 151.08

Reports Covered

Stock Research & News

View All

Profile

Monash IVF Group Limited provides assisted reproductive and specialist women imaging services in Australia and Malaysia. The company offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. It also provides tertiary level prenatal diagnostic, and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 and is based in Cremorne, Australia.

Monash IVF Group Ltd

510 Church Street, Cremorne, VIC, Australia, 3121

Key Executives

Name Title Year Born
Mr. Michael D. Knaap CEO, MD & Exec. Director NA
Mr. Malik Jainudeen Group CFO & Company Sec. NA
Dr. Hamish Hamilton Chief Operating Officer NA
Dr. Richard Charles Henshaw M.D. Exec. Director NA
Dr. Deirdre Zander-Fox BSc. (Hons.), Dip. of Mgt, Ph.D. Chief Scientific Officer NA
Mr. Thierry Panthier Chief Information Officer NA
Ms. Fiona Allen Chief Marketing Officer NA
Ms. Peggy North Chief People & Culture Officer NA
Ms. Tedd Fuell Chief Governance & Risk Officer NA
Ms. Clementina Singh Gen. Mang. of New South Wales NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.

Our Company

Useful Links

Contact Us

ISO Certified Market Research

Kalkine Solutions Private Limited, authorized representative of Kalkine Pty Ltd, holds ISO 27001:2022 certification bearing Certificate No.- IC-IS-2404072

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.